1/28
Comprehensive vocabulary flashcards covering ocular glycosaminoglycans, lysosomal storage diseases, eicosanoid biochemistry, thyroid hormone synthesis, and Graves' disease pathophysiology.
Glycosaminoglycans (GAGs)
Long, unbranched polymers of repeating disaccharide units (composed of an amino sugar and an acidic or second sugar) carrying negatively charged carboxylate and sulfate groups that attract cations and hold water.
Viscoelasticity
The mechanical property of a substance—such as hyaluronate in the vitreous—that enables it to deform under applied force and recover its original shape and volume.
Hyaluronate
An enormous, non-sulfated ocular glycosaminoglycan consisting of repeating glucuronic acid and N-acetylglucosamine units that exists as an unattached, free chain in the vitreous.
Decorin
A small corneal proteoglycan whose core protein binds type I collagen fibrils and carries a single chondroitin or dermatan sulfate chain that acts as a molecular spacer.
Lumican
A corneal proteoglycan that binds to type I collagen and bears keratan sulfate glycosaminoglycan chains to maintain stromal fibril spacing.
Keratocan
A corneal proteoglycan that attaches keratan sulfate chains and functions alongside other small leucine-rich proteoglycans to maintain corneal transparency.
Mimecan
A corneal proteoglycan that carries keratan sulfate chains and contributes to the uniform organization and spacing of collagen fibrils in the stroma.
Mucopolysaccharidoses (MPS)
A group of lysosomal storage diseases caused by inherited deficiencies of specific lysosomal enzymes responsible for breaking down glycosaminoglycans, leading to cellular engorgement and organ damage.
Hurler Syndrome (MPS I)
A severe autosomal recessive lysosomal storage disease caused by a deficiency of α-L-iduronidase, causing excessive storage of dermatan sulfate and heparan sulfate, severe corneal clouding, skeletal stiffness, and optic nerve damage.
Hunter Syndrome (MPS II)
An X-linked recessive mucopolysaccharidosis caused by a deficiency of iduronate-2-sulfatase, resulting in dermatan sulfate and heparan sulfate accumulation, mild or uncommon corneal clouding, and optic disc swelling or atrophy.
Sanfilippo Syndrome (MPS III)
An autosomal recessive lysosomal storage disease resulting from a defect in one of four heparan sulfate-degrading enzymes, marked by severe pigmentary retinal degeneration, mild optic nerve involvement, and usually insignificant corneal clouding.
Morquio Syndrome (MPS IV)
An autosomal recessive mucopolysaccharidosis caused by a deficiency of N-acetylgalactosamine-6-sulfatase (Type A) or β-galactosidase (Type B), characterized by keratan sulfate accumulation and mild to variable corneal clouding.
Maroteaux–Lamy Syndrome (MPS VI)
An autosomal recessive condition caused by a deficiency of N-acetylgalactosamine-4-sulfatase (arylsulfatase B), resulting in dermatan sulfate accumulation, severe corneal clouding, and moderate optic nerve damage without typical retinal degeneration.
Sly Syndrome (MPS VII)
An autosomal recessive lysosomal storage disease caused by a deficiency of β-glucuronidase, which leads to dermatan sulfate and heparan sulfate accumulation with variable corneal clouding.
Tay-Sachs Disease
An infantile-onset storage disorder caused by a deficiency of β-hexosaminidase A (HEXA gene), resulting in the toxic accumulation of GM2 ganglioside in neurons and the retina, clinically presenting with a macular cherry-red spot.
I-Cell Disease
A lysosomal trafficking disorder caused by a defect in GlcNAc-1-phosphotransferase, which prevents the addition of mannose-6-phosphate (M6P) tags and causes lysosomal enzymes to be secreted extracellularly rather than routed into lysosomes.
Eicosanoids
Locally acting signaling molecules produced by the oxidation of 20-carbon polyunsaturated fatty acids (such as arachidonic acid) that mediate inflammation, smooth muscle tone, and immunity.
Phospholipase A2
A membrane enzyme that hydrolyzes membrane phospholipids to release arachidonic acid upon activation by G-protein-coupled receptors or mechanical injury; its activity is inhibited by corticosteroids.
Prostaglandin H Synthase
A membrane-associated bifunctional enzyme with cyclooxygenase (COX) and peroxidase activities that converts free arachidonic acid into PGH2; it is inhibited by aspirin and NSAIDs.
12(R)-HETE
An eicosanoid synthesized by cytochrome P450 in the corneal epithelium that inhibits Na+/K+-ATPase in the corneal endothelium, contributing to corneal stromal swelling and inflammation.
PGF2α
A prostaglandin derivative that relaxes the ciliary muscle to promote uveoscleral outflow and lower intraocular pressure, providing the basis for topical prostaglandin-analog glaucoma medications.
Sodium-Iodide Symporter (NIS)
A transporter located on the basal membrane of thyroid follicular cells that drives the rate-limiting trapping of iodide, concentrating it 30–40-fold against its gradient using the sodium concentration gradient.
Thyroglobulin
A large, tyrosine-rich glycoprotein synthesized in thyroid follicular cells and secreted into the lumen colloid to serve as the protein scaffold for thyroid hormone synthesis and storage.
Thyroid Peroxidase (TPO)
An enzyme that uses H2O2 to oxidize iodide, attach it to tyrosyl residues in thyroglobulin (iodine organification), and couple MIT and DIT into T3 and T4.
Graves' Disease
The most common autoimmune cause of hyperthyroidism, mediated by autoantibodies against the TSH receptor that continuously stimulate thyroid hormone production and enlargement without destroying the gland.
Thyroid-Stimulating Immunoglobulin (TSI)
An activating autoantibody in Graves' disease that binds the TSH receptor on thyroid follicular cells and orbital fibroblasts, exerting an effect that is slower and longer lasting than endogenous TSH.
Thyroid Eye Disease (TED)
An autoimmune orbital disorder characterized by proptosis, eyelid retraction, and diplopia driven by TSI stimulation of orbital fibroblasts and preadipocytes, triggering hyaluronan synthesis, adipogenesis, and fluid retention.
Pretibial Myxedema
A clinical manifestation of Graves' disease characterized by a lumpy, reddish-orange thickening of the skin over the anterior shins, caused by local accumulation of glycosaminoglycans.
Zinc Finger
A structural protein motif within the DNA-binding domain of the intracellular nuclear receptor superfamily in which a zinc ion is coordinated by two cysteine and two histidine residues to bind target DNA sequences.